Skip to main content
Top
Published in: Endocrine Pathology 2/2008

01-06-2008

Characterization of C-Kit (CD117) Expression in Human Normal Pituitary Cells and Pituitary Adenomas

Authors: Stefano La Rosa, Silvia Uccella, Linda Dainese, Silvia Marchet, Claudia Placidi, Davide Vigetti, Carlo Capella

Published in: Endocrine Pathology | Issue 2/2008

Login to get access

Abstract

c-kit (CD117) is a tyrosine kinase receptor involved in the proliferation, differentiation, and secretory functions of various cells. In experimental animal models, c-kit has been detected in the pars intermedia of the normal pituitary gland and in α-melanocyte-stimulating-hormone-positive adenomas and it has been suggested that it plays a role in regulating adrenocorticotropic hormone (ACTH) secretion. To the best of our knowledge, the expression of c-kit in normal human pituitary cells and in pituitary adenomas has never been reported, so the possible biological role of this receptor in the control of pituitary hormone secretion remains unclear. The aim of this study was to evaluate the immunohistochemical expression of c-kit in normal human pituitary glands and in a series of 62 well-characterized pituitary adenomas. In normal adenohypophyses, several cells, mainly located in the central mucoid wedge, showed a c-kit immunoreactivity (IR). Double label immunostaining procedures showed that the c-kit-IR cells corresponded to ACTH cells. Out of 62 adenomas, 15 (24%) were c-kit-IR, including 7/16 (44%) ACTH cell, 3/7 (42%) null cell, 4/11 (36%) α-subunit cell, and 1/11 (10%) follicle-stimulating hormone–luteinizing hormone cell adenomas. By contrast, all ten prolactin cell and seven growth hormone cell adenomas were c-kit negative. These data suggest that, in normal conditions, c-kit may be involved in the pituitary–adrenal axis regulation.
Literature
1.
go back to reference Yarden Y, Kuang W, Yang-Feng T, Coussens L, Munemitsu S, Dull TJ, et al. Human proto-oncogene c-Kit: a new encoding cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 6:3341–51, 1987.PubMed Yarden Y, Kuang W, Yang-Feng T, Coussens L, Munemitsu S, Dull TJ, et al. Human proto-oncogene c-Kit: a new encoding cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 6:3341–51, 1987.PubMed
5.
go back to reference Demetri GD, von Mehren M, Blanke CD, Van den Abbeele AD, Eisenberg B, Roberts PJ, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 347:472–80, 2002. doi:10.1056/NEJMoa020461.PubMedCrossRef Demetri GD, von Mehren M, Blanke CD, Van den Abbeele AD, Eisenberg B, Roberts PJ, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 347:472–80, 2002. doi:10.​1056/​NEJMoa020461.PubMedCrossRef
7.
go back to reference Ishikubo T, Akagi K, Kurosumi M, Yamaguchi K, Fujimoto T, Sakamoto H, et al. Immunohistochemical and mutational analysis of c-kit in gastrointestinal neuroendocrine carcinoma. Jpn J Clin Oncol 36:494–8, 2006. doi:10.1093/jjco/hyl061.PubMedCrossRef Ishikubo T, Akagi K, Kurosumi M, Yamaguchi K, Fujimoto T, Sakamoto H, et al. Immunohistochemical and mutational analysis of c-kit in gastrointestinal neuroendocrine carcinoma. Jpn J Clin Oncol 36:494–8, 2006. doi:10.​1093/​jjco/​hyl061.PubMedCrossRef
8.
go back to reference Bernex F, De Sepulveda P, Kress C, Elbaz C, Delouis C, Panthier JJ. Spatial and temporal patterns of c-kit-expressing cells in WlacZ/+and WlacZ/WlacZ mouse embryos. Development 122:3023–33, 1996.PubMed Bernex F, De Sepulveda P, Kress C, Elbaz C, Delouis C, Panthier JJ. Spatial and temporal patterns of c-kit-expressing cells in WlacZ/+and WlacZ/WlacZ mouse embryos. Development 122:3023–33, 1996.PubMed
11.
go back to reference Natali PG, Nicotra MR, Sures I, Santoro E, Bigotti A, Ullrich A. Expression of c-kit receptor in normal and transformed human nonlymphoid tissues. Cancer Res 52:6139–43, 1992.PubMed Natali PG, Nicotra MR, Sures I, Santoro E, Bigotti A, Ullrich A. Expression of c-kit receptor in normal and transformed human nonlymphoid tissues. Cancer Res 52:6139–43, 1992.PubMed
12.
go back to reference Lammie A, Drobnjak M, Gerald W, Saad A, Cote R, Cordon-Cardo C. Expression of c-kit and kit ligand proteins in normal human tissues. J Histochem Cytochem 42:1417–25, 1994.PubMed Lammie A, Drobnjak M, Gerald W, Saad A, Cote R, Cordon-Cardo C. Expression of c-kit and kit ligand proteins in normal human tissues. J Histochem Cytochem 42:1417–25, 1994.PubMed
13.
go back to reference DeLellis RA, Lloyd RV, Heitz PU, et al. WHO classification of tumours. Pathology and genetics of tumours of endocrine organs. Lyon: IARC, 2004. DeLellis RA, Lloyd RV, Heitz PU, et al. WHO classification of tumours. Pathology and genetics of tumours of endocrine organs. Lyon: IARC, 2004.
14.
go back to reference Hsu SM, Raine L, Fanger H. Use of avidin–biotin–peroxidase complex (ABC) in immunoperoxidase technique. J Histochem Cytochem 25:577–89, 1981. Hsu SM, Raine L, Fanger H. Use of avidin–biotin–peroxidase complex (ABC) in immunoperoxidase technique. J Histochem Cytochem 25:577–89, 1981.
15.
go back to reference Mason DY, Abdulaziz B, Falini H, Stein H. Double immunoenzymatic labelling. In: Polak, JM, Van Noorden, S, eds. Immunocytochemistry. Practical applications in pathology and biology. Wright: Bristol, pp. 113–28, 1983. Mason DY, Abdulaziz B, Falini H, Stein H. Double immunoenzymatic labelling. In: Polak, JM, Van Noorden, S, eds. Immunocytochemistry. Practical applications in pathology and biology. Wright: Bristol, pp. 113–28, 1983.
16.
go back to reference Lan HY, Mu W, Nikolic-Paterson DJ, Atkins RC. A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: use of microwave oven heating to block antibody cross-reactivity and retrieve antigens. J Histochem Cytochem 43:97–102, 1995.PubMed Lan HY, Mu W, Nikolic-Paterson DJ, Atkins RC. A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: use of microwave oven heating to block antibody cross-reactivity and retrieve antigens. J Histochem Cytochem 43:97–102, 1995.PubMed
17.
18.
go back to reference Sarlomo-Rikala M, Kovatich AJ, Barusevicius A, Miettinen M. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol 11:728–34, 1998.PubMed Sarlomo-Rikala M, Kovatich AJ, Barusevicius A, Miettinen M. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol 11:728–34, 1998.PubMed
23.
go back to reference Broudy VC, Lin NL, Liles CL, Corey SJ, O'Laughlin B, Mou S, et al. Signaling via src family kinases is required for normal internalization of the receptor c-Kit. Blood 94:1979–86, 1999.PubMed Broudy VC, Lin NL, Liles CL, Corey SJ, O'Laughlin B, Mou S, et al. Signaling via src family kinases is required for normal internalization of the receptor c-Kit. Blood 94:1979–86, 1999.PubMed
24.
go back to reference La Rosa S, Uccella S, Capella C, Chiaravalli AM, Sessa F. Localization of acidic fibroblast growth factor, fibroblast growth factor receptor-4, transforming growth factor-α, and epidermal growth factor receptor in human endocrine cells of the gut and related tumors: an immunohistochemical study. Appl Immunohistochem 6:199–208, 1998. doi:10.1097/00022744-199812000-00005.CrossRef La Rosa S, Uccella S, Capella C, Chiaravalli AM, Sessa F. Localization of acidic fibroblast growth factor, fibroblast growth factor receptor-4, transforming growth factor-α, and epidermal growth factor receptor in human endocrine cells of the gut and related tumors: an immunohistochemical study. Appl Immunohistochem 6:199–208, 1998. doi:10.​1097/​00022744-199812000-00005.CrossRef
25.
go back to reference La Rosa S, Uccella S, Capella C, Erba S, Sessa F. Localization of hepatocyte growth factor and its receptor met in endocrine cells and related tumors of the gut and pancreas: an immunohistochemical study. Endocr Pathol 11:315–29, 2000. doi:10.1385/EP:11:4:315.PubMedCrossRef La Rosa S, Uccella S, Capella C, Erba S, Sessa F. Localization of hepatocyte growth factor and its receptor met in endocrine cells and related tumors of the gut and pancreas: an immunohistochemical study. Endocr Pathol 11:315–29, 2000. doi:10.​1385/​EP:​11:​4:​315.PubMedCrossRef
26.
go back to reference La Rosa S, Uccella S, Erba S, Capella C, Sessa F. Immunohistochemical detection of fibroblast growth factor receptors in normal endocrine cells and related tumors of the digestive system. Appl Immunohistochem Mol Morphol 9:319–28, 2001. doi:10.1097/00022744-200112000-00006.PubMedCrossRef La Rosa S, Uccella S, Erba S, Capella C, Sessa F. Immunohistochemical detection of fibroblast growth factor receptors in normal endocrine cells and related tumors of the digestive system. Appl Immunohistochem Mol Morphol 9:319–28, 2001. doi:10.​1097/​00022744-200112000-00006.PubMedCrossRef
27.
go back to reference La Rosa S, Uccella S, Finzi G, Albarello L, Sessa F, Capella C. Localization of vascular endothelial growth factor and its receptors in digestive endocrine tumors: correlation with microvessel density and clinicopathologic features. Human Pathol 34:18–27, 2003. doi:10.1053/hupa.2003.56.CrossRef La Rosa S, Uccella S, Finzi G, Albarello L, Sessa F, Capella C. Localization of vascular endothelial growth factor and its receptors in digestive endocrine tumors: correlation with microvessel density and clinicopathologic features. Human Pathol 34:18–27, 2003. doi:10.​1053/​hupa.​2003.​56.CrossRef
28.
go back to reference La Rosa S, Celato N, Uccella S, Capella C. Detection of gonadotropin-releasing hormone receptor in normal human pituitary cells and pituitary adenomas using immunohistochemistry. Virchows Arch 437:264–9, 2000. doi:10.1007/s004280000247.PubMedCrossRef La Rosa S, Celato N, Uccella S, Capella C. Detection of gonadotropin-releasing hormone receptor in normal human pituitary cells and pituitary adenomas using immunohistochemistry. Virchows Arch 437:264–9, 2000. doi:10.​1007/​s004280000247.PubMedCrossRef
29.
go back to reference Dournaud P, Boudin H, Schonbrunn A, Tannenbaum GS, Beaudet A. Interrelationships between somatostatin sst2A receptors and somatostatin-containing axons in rat brain: evidence for regulation of cell surface receptors by endogenous somatostatin. J Neurosci 18:1056–71, 1998.PubMed Dournaud P, Boudin H, Schonbrunn A, Tannenbaum GS, Beaudet A. Interrelationships between somatostatin sst2A receptors and somatostatin-containing axons in rat brain: evidence for regulation of cell surface receptors by endogenous somatostatin. J Neurosci 18:1056–71, 1998.PubMed
30.
go back to reference Mertani HC, Pechoux C, Garcia-Caballero T, Waters MJ, Morel G. Cellular localization of the growth hormone receptor/binding protein in the human anterior pituitary gland. J Clin Endocrinol Metab 80:3361–7, 1995. doi:10.1210/jc.80.11.3361.PubMedCrossRef Mertani HC, Pechoux C, Garcia-Caballero T, Waters MJ, Morel G. Cellular localization of the growth hormone receptor/binding protein in the human anterior pituitary gland. J Clin Endocrinol Metab 80:3361–7, 1995. doi:10.​1210/​jc.​80.​11.​3361.PubMedCrossRef
32.
go back to reference Chen J, Hermus N, Van Duppen V, Caesens P, Denef C, Vankelecom H. The adult pituitary contains a cell population displaying stem/progenitor cell and early embryonic characteristics. Endocrinology 146:2985–98, 2005. doi:10.1210/en.2005-0178.CrossRef Chen J, Hermus N, Van Duppen V, Caesens P, Denef C, Vankelecom H. The adult pituitary contains a cell population displaying stem/progenitor cell and early embryonic characteristics. Endocrinology 146:2985–98, 2005. doi:10.​1210/​en.​2005-0178.CrossRef
33.
go back to reference Sano T, Yamada S. Histologic and immunohistochemical study of clinically non-functioning pituitary adenomas: special reference to gonadotropin-positive adenomas. Pathol Int 44:697–703, 1994.PubMed Sano T, Yamada S. Histologic and immunohistochemical study of clinically non-functioning pituitary adenomas: special reference to gonadotropin-positive adenomas. Pathol Int 44:697–703, 1994.PubMed
34.
go back to reference Riva C, Leutner M, Capella C, Usellini L, La Rosa S, Brianza R, Buffa R. Different expression of chromogranin A and chromogranin B in various types of pituitary adenomas. Zentralbl Pathol 139:165–70, 1993.PubMed Riva C, Leutner M, Capella C, Usellini L, La Rosa S, Brianza R, Buffa R. Different expression of chromogranin A and chromogranin B in various types of pituitary adenomas. Zentralbl Pathol 139:165–70, 1993.PubMed
35.
go back to reference Remotti D, Graziano P, Macciomei MC, Manente L, Silvestri E, Nunnari J, et al. Unmutated kit expression in neuroendocrine thymic carcinoma: an immunohistochemical and molecular study of five cases. Pathologica 99:139, 2007. Remotti D, Graziano P, Macciomei MC, Manente L, Silvestri E, Nunnari J, et al. Unmutated kit expression in neuroendocrine thymic carcinoma: an immunohistochemical and molecular study of five cases. Pathologica 99:139, 2007.
36.
go back to reference Gross DJ, Munter G, Bitan M, Siegal T, Gabizon A, Weitzen R, et al. The role of imatinib mesylate (glivec) for treatment of patients with malignant endocrine tumors positive for c-kit or PDGF-R. Endocr Relat Cancer 13:535–40, 2006. doi:10.1677/erc.1.01124.PubMedCrossRef Gross DJ, Munter G, Bitan M, Siegal T, Gabizon A, Weitzen R, et al. The role of imatinib mesylate (glivec) for treatment of patients with malignant endocrine tumors positive for c-kit or PDGF-R. Endocr Relat Cancer 13:535–40, 2006. doi:10.​1677/​erc.​1.​01124.PubMedCrossRef
37.
go back to reference Tsuura Y, Hiraki H, Watanabe K, Igarashi S, Shimamura K, Fukuda T, et al. Preferential localization of c-kit product in tissue mast cells, basal cells of the skin, epithelial cells of the breast, small cell lung carcinoma and seminoma/dysgerminoma in human: immunohistochemical study on formalin-fixed, paraffin-embedded tissues. Virchows Arch 424:135–41, 1994. doi:10.1007/BF00193492.PubMedCrossRef Tsuura Y, Hiraki H, Watanabe K, Igarashi S, Shimamura K, Fukuda T, et al. Preferential localization of c-kit product in tissue mast cells, basal cells of the skin, epithelial cells of the breast, small cell lung carcinoma and seminoma/dysgerminoma in human: immunohistochemical study on formalin-fixed, paraffin-embedded tissues. Virchows Arch 424:135–41, 1994. doi:10.​1007/​BF00193492.PubMedCrossRef
38.
go back to reference Fjällskog MLH, Lejonklou MH, Öberg KE, Eriksson BK, Janson ET. Expression of molecular targets for tyrosine kinase receptor antagonist in malignant endocrine pancreatic tumors. Clin Cancer Res 9:1469–73, 2003.PubMed Fjällskog MLH, Lejonklou MH, Öberg KE, Eriksson BK, Janson ET. Expression of molecular targets for tyrosine kinase receptor antagonist in malignant endocrine pancreatic tumors. Clin Cancer Res 9:1469–73, 2003.PubMed
39.
42.
go back to reference Matsuda R, Takahashi T, Nakamura S, Sekido Y, Nishida K, Seto M, et al. Expression of the c-kit protein in human solid tumors and in corresponding fetal and adult normal tissues. Am J Pathol 142:339–46, 1993.PubMed Matsuda R, Takahashi T, Nakamura S, Sekido Y, Nishida K, Seto M, et al. Expression of the c-kit protein in human solid tumors and in corresponding fetal and adult normal tissues. Am J Pathol 142:339–46, 1993.PubMed
Metadata
Title
Characterization of C-Kit (CD117) Expression in Human Normal Pituitary Cells and Pituitary Adenomas
Authors
Stefano La Rosa
Silvia Uccella
Linda Dainese
Silvia Marchet
Claudia Placidi
Davide Vigetti
Carlo Capella
Publication date
01-06-2008
Publisher
Humana Press Inc
Published in
Endocrine Pathology / Issue 2/2008
Print ISSN: 1046-3976
Electronic ISSN: 1559-0097
DOI
https://doi.org/10.1007/s12022-008-9032-4

Other articles of this Issue 2/2008

Endocrine Pathology 2/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.